NYC Nurses Strike Shuts Down 10 Private Hospitals as 15,000 Demand Safer Staffing and Benefits 
Tesla, EEOC Move Toward Mediation in Racial Harassment Lawsuit 
xAI Restricts Grok Image Editing After Sexualized AI Images Trigger Global Scrutiny 
Saks Global Files for Bankruptcy Protection Amid Mounting Luxury Retail Pressures 
Netflix Plans All-Cash Bid for Warner Bros Discovery Studios Amid Intense Hollywood Takeover Battle 
AbbVie Commits $100 Billion to U.S. Investment in Drug Pricing Deal With Trump Administration 
China Considers New Rules to Limit Purchases of Foreign AI Chips Amid Growing Demand 
Boeing Reaches Tentative Settlement With Canadian Victim’s Family in 737 MAX Crash Lawsuits 
Trump Pushes Tech Giants to Absorb AI Data Center Power Costs, Citing Microsoft Changes 
BlackRock to Cut Around 250 Jobs as CEO Larry Fink Pushes Strategic Shift 
TSMC Set to Post Record Q4 Profit as AI Chip Demand Accelerates 
Nvidia Denies Upfront Payment Requirement for H200 AI Chips Amid China Export Scrutiny 
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market 
Coca-Cola Shelves Costa Coffee Sale After Low Private Equity Offers 
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio 
Zhipu AI Launches GLM-Image Model Trained on Huawei Chips, Boosting China’s AI Self-Reliance Drive 
NEW YORK, April 04, 2017 -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of USANA Health Sciences, Inc. (NYSE:USNA) who purchased shares between March 14, 2014 and February 7, 2017. The action, which was filed in United States District Court for the District of Utah, alleges that the Company violated federal securities laws.
In particular, the complaint alleges that throughout the Class Period, defendants made materially false and/or misleading statements and/or failed to disclose that (i) the Company's BabyCare Ltd. subsidiary had engaged in improper reimbursement practices in China; (ii) these practices constituted violations of the Foreign Corrupt Practices Act; (iii) as such, the Company’s China revenues were in part the product of unlawful conduct and unlikely to be sustainable; (iv) the foregoing conduct was likely to subject the Company to significant regulatory scrutiny; and (v) as a result of the foregoing, USANA’s public statements were materially false and misleading at all relevant times.
On February 7, 2017, post-market, USANA disclosed that “[t]he Company is voluntarily conducting an internal investigation of its China operations, BabyCare Ltd. The investigation focuses on compliance with the Foreign Corrupt Practices Act . . . and certain conduct and policies at BabyCare, including BabyCare's expense reimbursement policies.” Upon this news, shares of USANA were down more than 10% on intraday trading on February 8, 2017.
Shareholders have until April 14, 2017 to petition the court for lead plaintiff status. Your ability to share in any recovery does not require that you serve as lead plaintiff. You may choose to be an absent class member.
If you suffered a loss during the class period and wish to obtain additional information, please contact Joseph Klein, Esq. by telephone at 212-616-4899 or visit www.kleinstocklaw.com.
Joseph Klein, Esq. is an experienced attorney and has also practiced as a Certified Public Accountant. Mr. Klein represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Joseph Klein, Esq. 2926 Avenue L Brooklyn, NY 11210 Telephone: (212) 616-4899 Fax: (347) 558-9665 www.kleinstocklaw.com
